Charles Schwab’s Abeona Therapeutics ABEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$763K Buy
134,352
+109,895
+449% +$624K ﹤0.01% 2988
2025
Q1
$116K Buy
24,457
+607
+3% +$2.89K ﹤0.01% 3319
2024
Q4
$133K Hold
23,850
﹤0.01% 3372
2024
Q3
$151K Buy
+23,850
New +$151K ﹤0.01% 3357
2023
Q2
Sell
-18,000
Closed -$50.8K 3609
2023
Q1
$50.8K Buy
+18,000
New +$50.8K ﹤0.01% 3345
2022
Q1
Sell
-1,411
Closed -$12K 3580
2021
Q4
$12K Hold
1,411
﹤0.01% 3587
2021
Q3
$40K Hold
1,411
﹤0.01% 3470
2021
Q2
$56K Sell
1,411
-5,141
-78% -$204K ﹤0.01% 3351
2021
Q1
$308K Buy
6,552
+761
+13% +$35.8K ﹤0.01% 3234
2020
Q4
$228K Hold
5,791
﹤0.01% 3237
2020
Q3
$148K Hold
5,791
﹤0.01% 3219
2020
Q2
$423K Sell
5,791
-215
-4% -$15.7K ﹤0.01% 2898
2020
Q1
$316K Buy
6,006
+2,895
+93% +$152K ﹤0.01% 2873
2019
Q4
$255K Hold
3,111
﹤0.01% 3006
2019
Q3
$176K Hold
3,111
﹤0.01% 3054
2019
Q2
$372K Buy
3,111
+372
+14% +$44.5K ﹤0.01% 2944
2019
Q1
$505K Buy
2,739
+41
+2% +$7.56K ﹤0.01% 2765
2018
Q4
$482K Hold
2,698
﹤0.01% 2782
2018
Q3
$864K Buy
2,698
+184
+7% +$58.9K ﹤0.01% 2665
2018
Q2
$1.01M Hold
2,514
﹤0.01% 2582
2018
Q1
$902K Buy
2,514
+260
+12% +$93.3K ﹤0.01% 2547
2017
Q4
$894K Buy
2,254
+610
+37% +$242K ﹤0.01% 2541
2017
Q3
$701K Hold
1,644
﹤0.01% 2618
2017
Q2
$264K Buy
+1,644
New +$264K ﹤0.01% 2915
2016
Q2
Sell
-585
Closed -$38K 3104
2016
Q1
$38K Hold
585
﹤0.01% 3034
2015
Q4
$50K Hold
585
﹤0.01% 3071
2015
Q3
$60K Hold
585
﹤0.01% 3060
2015
Q2
$74K Buy
+585
New +$74K ﹤0.01% 3060